Marisa Tungsiripat is an Infectious Disease physician affiliated with Cleveland Clinic. OpenAlex indexes 25 publications with 752 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
800-223-2273Registry record last updated 22 Feb 2008.
Clinical trials
- Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Sponsor: The Cleveland Clinic
- Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Tetracycline-class Drug34.9%Doxycycline Monohydrate100%Part D<11 patientsGlycopeptide Antibacterial25.4%Vancomycin Hcl100%Part D≥13 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Metabolic Complications of HIV and Responses to Pioglitazone
Cleveland Clinic Lerner Com-Cwru
FY2011$129,060K23AI070078 - Metabolic Complications of HIV and Responses to Pioglitazone
Cleveland Clinic Lerner Com-Cwru
FY2010$129,060K23AI070078 - Metabolic Complications of HIV and Responses to Pioglitazone
Cleveland Clinic Lerner Com-Cwru
FY2009$129,060K23AI070078
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence of <i>Neisseria meningitidis</i> by Molecular Testing in Urine Specimens From Men in Ohio
Open Forum Infectious Diseases
2025 - Preanalytic process linked to spuriously elevated HIV viral loads: improvement on an FDA-approved process
Diagnostic Microbiology and Infectious Disease
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”